Clinical Investigations: ElectrophysiologyObservations on the transition from intermittent to permanent atrial fibrillation☆,☆☆,★
Section snippets
Patients
The population of this study was a cohort of patients seen for atrial fibrillation in a hospital-based clinic by the same cardiologist from January 1978 through December 1997. To be considered for inclusion in the study, a patient had to have at least one episode of atrial fibrillation documented by a 12-lead electrocardiogram or by a transtelephonic rhythm strip. The electrocardiographic criteria for atrial fibrillation were a grossly irregular rhythm and the absence of discernible P waves.
Results
Three hundred thirty-one patients seen between January 1978 and December 1997 had documented atrial fibrillation. Some of the patients were excluded; 59 patients had permanent atrial fibrillation at presentation, 19 had Wolff-Parkinson-White syndrome, 2 had a history of His bundle ablation, 13 had pure atrial flutter, 6 had atrial fibrillation attributable to reversible causes, and 1 had concomitant ventricular arrhythmias requiring antiarrhythmic therapy. The remaining 231 patients were
Discussion
This study provides a quantitative estimate of the proportion of unselected patients with intermittent atrial fibrillation who progressed to permanent atrial fibrillation. This report shows that age and being in atrial fibrillation at presentation are strong predictors of such a progression. Despite the increasing incidence and high morbidity rates of atrial fibrillation, there are few studies that have addressed this aspect of atrial fibrillation in a quantitative fashion.
One previous natural
References (10)
- et al.
Coronary heart disease and atrial fibrillation: The Framingham study
Am Heart J
(1983) - et al.
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study
Arch Intern Med
(1987) - et al.
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study
Neurology
(1978) - et al.
Atrial fibrillation as an independent risk factor for stroke: The Framingham study
Stroke
(1991) - et al.
Classification of atrial fibrillation
PACE
(1998)
Cited by (66)
Predicting spontaneous termination of atrial fibrillation based on dual path network and feature selection
2024, Biomedical Signal Processing and ControlComprehensive analysis of heart rate variability features for accurate prediction of paroxysmal atrial fibrillation
2024, Biomedical Signal Processing and ControlPrediction of paroxysmal atrial fibrillation using new heart rate variability features
2021, Computers in Biology and MedicineCitation Excerpt :AF patients often start with episodes of PAF before their condition escalates to a chronic stage. Furthermore, about 18% of PAF evolves to permanent AF (persistent or chronic) over 4 years [6]. AF can be treated by medication or electrical shock issued by the implantable defibrillator device (ICD) [7].
Prediction of paroxysmal Atrial Fibrillation: A machine learning based approach using combined feature vector and mixture of expert classification on HRV signal
2018, Computer Methods and Programs in BiomedicineCitation Excerpt :Nevertheless, it is often associated with a high risk of cardiovascular morbidity and mortality [9]. The aim of therapy is to prevent stroke and regain sinus rhythm [10], however, prevention and treatment of AF is still far from satisfactory. Clinically, AF presents itself in different forms, commonly starting as paroxysmal, and becoming more persistent with time.
Paroxysmal atrial fibrillation prediction method with shorter HRV sequences
2016, Computer Methods and Programs in BiomedicineAssessment of anticoagulation treatments in non-valvular atrial fibrillation patients diagnosed in a basic health area
2018, Clinica e Investigacion en Arteriosclerosis
- ☆
Dr Pritchett’s research in supraventricular arrhythmias has been supported by grant M01-RR00030 from the National Center for Research Resources, National Institutes of Health, Bethesda, Maryland.
- ☆☆
Guest Editor for this manuscript was Gust H. Bardy, MD, University of Washington, Seattle.
- ★
Reprint requests: Sana Al-Khatib, MD, Duke University Medical Center, Box 31071, Durham, NC 27710. E-mail: [email protected]